CME Group Inc. (NASDAQ:CME) Receives Average Rating of “Hold” from Brokerages

CME Group Inc. (NASDAQ:CME) has earned a consensus recommendation of “Hold” from the eleven brokerages that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell recommendation, five have given a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $213.27.

CME has been the subject of a number of research reports. Piper Sandler restated an “overweight” rating and set a $225.00 price objective on shares of CME Group in a research report on Tuesday. Keefe, Bruyette & Woods raised their price objective on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Barclays lifted their price target on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a report on Thursday, July 25th. JPMorgan Chase & Co. lifted their price target on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, August 15th.

CME Group Trading Down 1.2 %

Shares of NASDAQ CME opened at $207.05 on Friday. CME Group has a one year low of $190.70 and a one year high of $223.80. The firm has a market capitalization of $74.55 billion, a PE ratio of 23.56, a PEG ratio of 6.27 and a beta of 0.52. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. The business has a 50-day moving average price of $199.69 and a two-hundred day moving average price of $207.14.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period last year, the company posted $2.30 EPS. The business’s quarterly revenue was up 12.7% compared to the same quarter last year. As a group, analysts predict that CME Group will post 9.8 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date is Monday, September 9th. CME Group’s payout ratio is 52.33%.

Insider Activity at CME Group

In related news, Director Charles P. Carey sold 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the transaction, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other CME Group news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction that occurred on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the transaction, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Daniel R. Glickman sold 650 shares of CME Group stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $201.44, for a total value of $130,936.00. Following the completion of the transaction, the director now directly owns 14,008 shares in the company, valued at $2,821,771.52. The disclosure for this sale can be found here. 0.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in CME. Second Half Financial Partners LLC bought a new stake in shares of CME Group during the fourth quarter valued at approximately $2,737,000. Raymond James Financial Services Advisors Inc. increased its position in shares of CME Group by 2.3% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 1,041,526 shares of the financial services provider’s stock valued at $224,230,000 after purchasing an additional 23,340 shares during the period. Bluefin Capital Management LLC bought a new stake in shares of CME Group during the fourth quarter valued at approximately $2,891,000. Alaska Permanent Fund Corp increased its position in shares of CME Group by 81.4% during the first quarter. Alaska Permanent Fund Corp now owns 44,534 shares of the financial services provider’s stock valued at $9,588,000 after purchasing an additional 19,985 shares during the period. Finally, Western Pacific Wealth Management LP increased its position in shares of CME Group by 20.2% during the fourth quarter. Western Pacific Wealth Management LP now owns 523 shares of the financial services provider’s stock valued at $110,000 after purchasing an additional 88 shares during the period. 87.75% of the stock is owned by institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.